Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/22/2009 | CA2700586A1 Clonidine formulations in a biodegradable polymer carrier |
10/22/2009 | CA2700578A1 Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
10/22/2009 | CA2700389A1 Methods and compositions for treating post-operative pain comprising clonidine |
10/22/2009 | CA2700002A1 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
10/21/2009 | EP2110142A2 Inhibition of secretion from non-neuronal cells |
10/21/2009 | EP2110131A1 Anti-tumor composition comprising tissue-accumulating chitosan gel |
10/21/2009 | EP2109619A2 Modifications of peptide compositions to increase stability and delivery efficiency |
10/21/2009 | EP2109465A2 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same |
10/21/2009 | EP2109464A1 Polymers of aliphatic thioester |
10/21/2009 | EP2109454A1 Glp-1 pharmaceutical compositions |
10/21/2009 | EP2109448A2 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
10/21/2009 | EP2109443A1 Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium |
10/21/2009 | EP2109442A2 Ophthalmic compositions containing a synergistic combination of three polymers |
10/21/2009 | EP1874797B1 Method of preparing grafted polylysine dendrimers |
10/21/2009 | EP1637131B1 Cataplasm base and cataplasm using the same |
10/21/2009 | EP1512404B1 External preparations for treating dermatitis |
10/21/2009 | EP1509533B1 Polyol-modified silanes as precursors for silica |
10/21/2009 | EP1479300B1 Amino acid powder and process for producing the same |
10/21/2009 | EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
10/21/2009 | EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors |
10/21/2009 | EP1169062B1 Heat stable coated colloidal iron oxides |
10/21/2009 | EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances |
10/21/2009 | EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
10/21/2009 | CN101563066A Dispersion of polyamino acids in a continuous lipid phase |
10/21/2009 | CN101560718A Method for preparing functional nano fibrous membrane by multi-component consolute single-step method |
10/21/2009 | CN101560259A Method for preparing multifunctional Tylose by plant fibre |
10/21/2009 | CN101559241A Hyaluronic acid-hydroxyapatite nano composite sphere and preparation method |
10/21/2009 | CN101559231A High shearing production method for film coating agent |
10/21/2009 | CN101559230A Special solvent of lansoprazole lyophilized powder for injection |
10/21/2009 | CN101559229A Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area |
10/21/2009 | CN101559228A Pharmaceutical composition for treating chronic stable angina pectoris with hyperlipemia |
10/21/2009 | CN101559225A Meningococcus vaccine |
10/21/2009 | CN101559223A Idemic encephalitis diphtheria-pertussis-tetanus combined vaccine |
10/21/2009 | CN101559219A Preparation for phimosis, andrological inflammation and sexual disorder and production method thereof |
10/21/2009 | CN101559202A Zedoary turmeric oil adhesive membrane for external application and preparation method thereof |
10/21/2009 | CN101559198A Medicament for protecting joints and soft tissues |
10/21/2009 | CN101559116A Stable Chinese medicinal freckle-removing soft capsule and preparation method thereof |
10/21/2009 | CN101559103A Sterilizing and itching-relieving medical composition |
10/21/2009 | CN101559100A Acesodyne capsule for heart and stomach |
10/21/2009 | CN101559074A Coccidiostat-decoquinate dry suspension for livestock and poultry and preparation method thereof |
10/21/2009 | CN101559059A Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof |
10/21/2009 | CN101559056A Oral pharmaceutical composition containing lansoprazole and domperidone |
10/21/2009 | CN101559043A Benzene sulfonic acid levo-amlodipine pill and preparation method thereof |
10/21/2009 | CN101559041A Polypeptide medicament sustained release microsphere or microcapsule preparation with uniform grain size and preparation method thereof |
10/21/2009 | CN101559040A Medicament composition of cefotiam hydrochloride and preparation thereof |
10/21/2009 | CN101559039A Method for producing nattokinase liposome from phytosterol |
10/21/2009 | CN101559038A Solid lipid nanoparticles of finasteride and preparation method thereof |
10/21/2009 | CN101559037A Binary solution type preparation for intravenous injection and intracerebral injection |
10/21/2009 | CN101559036A Conception control gel composition for vagina as well as preparation method and application thereof |
10/21/2009 | CN100552016C Bifidobacterium in treatment of inflammatory disease |
10/21/2009 | CN100551911C Polyphenols compound modified by azo-containing heterocyclic and use thereof |
10/21/2009 | CN100551910C Styryl compound modified by azo-containing heterocyclic and use thereof |
10/21/2009 | CN100551445C Self assembled precusor liposome containing hard soluble medicine and its preparation method |
10/21/2009 | CN100551444C Stabilization of solid thyroid drug formulations |
10/21/2009 | CN100551443C Nano carbon tube infusion agent preparation method |
10/21/2009 | CN100551441C Compositions comprising neisseria meningitidis sero-group B and C and other antigen |
10/21/2009 | CN100551440C Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method |
10/21/2009 | CN100551439C Long acting injectable insulin composition and methods of making and using thereof |
10/21/2009 | CN100551435C Moistureproof coating method of Xiaojianzhong capsule |
10/21/2009 | CN100551386C Dry coating sustained-release tablet for treating arthritis and preparation process thereof |
10/21/2009 | CN100551384C Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation |
10/21/2009 | CN100551378C Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
10/21/2009 | CN100551377C Bisphosphonic acid for the treatment and prevention of osteoporosis |
10/21/2009 | CN100551376C Antibiotic slow-release preparation for local use |
10/21/2009 | CN100551369C Sustained release preparation containing cilostazol and its preparation method |
10/21/2009 | CN100551368C Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
10/21/2009 | CN100551363C A solid dosage form comprising a fibrate |
10/21/2009 | CN100551358C Method for making particles for use in a pharmaceutical composition |
10/21/2009 | CN100551345C Stable topical drug delivery compositions |
10/20/2009 | US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
10/20/2009 | US7605233 Tumour necrosis factor binding ligands |
10/20/2009 | US7605232 Hydrogels for protein concentration |
10/20/2009 | US7605231 Having organic compound as graft chain and high-molecular weight micelle containing the gelatin derivative; as organic compound, a low molecular weight compound such as succinic acid, ethylenediamine, or high-molecular weight compound such as polyethylene glycol can be used; adhesion preventing membrane |
10/20/2009 | US7605178 Therapeutic compounds |
10/20/2009 | US7605173 Pharmaceutical liquid composition containing pyridone derivative |
10/20/2009 | US7605141 Preserving vitamins subject to oxidative damage by adding a sufficient amount of purified nucleic acid to vitamin such that the rate of oxidative damage of the vitamin is reduced |
10/20/2009 | US7605136 Epothilone - saccharide complex; antiproliferative agents; antitumor agents; antiinflammatory agents; central nervous system disorders; multiple sclerosis; Alzheimer's disease; rheumatic disorders; antiarthritic agents |
10/20/2009 | US7605125 Anticancer agents |
10/20/2009 | US7605124 an ejection liquid for stably ejecting a solution containing at least one kind of insulin ( polyoxyethylene glycol or polyvinyl alcohol modified insulin), citric acid and a surfactant; ejecting the liquid by a thermal inkjet system |
10/20/2009 | US7605121 Oligopeptide lyophilisate, their preparation and use |
10/20/2009 | US7605120 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis |
10/20/2009 | US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product |
10/20/2009 | US7604812 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins |
10/20/2009 | US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic |
10/20/2009 | US7604797 Compositions and methods for treating burns |
10/20/2009 | US7604185 Generation of therapeutic microfoam |
10/20/2009 | CA2531833C Poly-4-hydroxybutyrate matrices for sustained drug delivery |
10/20/2009 | CA2492854C Sustained-release tablet composition of pramipexole |
10/20/2009 | CA2481593C Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin |
10/20/2009 | CA2446712C System for osmotic delivery of pharmaceutically active agents |
10/20/2009 | CA2415782C Dermatological composition comprising a multiplicity of particles |
10/20/2009 | CA2413088C Preservative |
10/20/2009 | CA2402267C Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
10/20/2009 | CA2393638C Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
10/20/2009 | CA2389349C Aerosol composition comprising formoterol |
10/20/2009 | CA2376894C Pharmaceutical composition comprising a protein and an ectoine |
10/20/2009 | CA2376226C New formulation |
10/20/2009 | CA2360110C Sustained release salts of pharmaceutically active peptides and their production |
10/20/2009 | CA2354705C Process for producing deoiled phosphatides |
10/20/2009 | CA2339482C Composite hydrogel drug delivery systems |